DTC genetics company Nucleus Genomics raises $14M

2022 07 15 19 56 0503 Genetics Dna Money 400

Consumer genetic testing and analysis company Nucleus Genomics has announced it has raised $14 million in a financing round led by Seven Seven Six.

The New York City-based company said it is building a DTC genetic testing platform that provides genetic risk and disposition score analyses on an extensive number of diseases and traits by leveraging whole-genome sequencing.

The company said that the additional funding, along with the company's initial seed financing raised in 2021, will help Nucleus bolster its scientific and engineering team.

The firm is establishing the computational and physical infrastructure required to analyze whole-genome sequencing data at scale, customize disease and trait reports, and send genetic testing kits to users.

Page 1 of 8
Next Page